2,203
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

, , , , , , , , , , , , , , ORCID Icon & show all
Article: 1760705 | Received 25 Jul 2019, Accepted 30 Jan 2020, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jing Xue, Xia Yan, Qin Ding, Nan Li, Menghan Wu & Jianbo Song. (2023) Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours. Annals of Medicine 55:2.
Read now
S. T. Paijens, A. Vledder, D. Loiero, E. W. Duiker, J. Bart, A. M. Hendriks, M. Jalving, H. H. Workel, H. Hollema, N. Werner, A. Plat, G. B. A. Wisman, R. Yigit, H. Arts, A. J. Kruse, N.M. de Lange, V. H. Koelzer, M. de Bruyn & H. W. Nijman. (2021) Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients. OncoImmunology 10:1.
Read now
Yunyun Li, Xiaoling Gan, Fei Li & Lina Hu. The Putative Effects of Neoadjuvant Chemotherapy on the Immune System of Advanced Epithelial Ovarian Carcinoma. Immunological Investigations 0:0, pages 1-24.
Read now

Articles from other publishers (8)

Yuan Li, Yuanlu Shu, Kun Yu, Ruihan Ni & Lan Chu. (2024) Analysis and Regulatory Mechanisms of Platelet-Related Genes in Patients with Ischemic Stroke. Cellular and Molecular Neurobiology 44:1.
Crossref
Faizah Alotaibi, Kanaan Alshammari, Badi A. Alotaibi & Hashem Alsaab. (2024) Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. Frontiers in Pharmacology 14.
Crossref
Galaxia M. Rodriguez, Edward Yakubovich & Barbara C. Vanderhyden. (2023) Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success. Cancers 15:23, pages 5694.
Crossref
Kaiyuan Chai, Chuanlei Wang, Jianpeng Zhou, Wentao Mu, Menghan Gao, Zhongqi Fan & Guoyue Lv. (2023) Quenching thirst with poison? Paradoxical effect of anticancer drugs. Pharmacological Research 198, pages 106987.
Crossref
Jitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, Peter Holicek, Tereza Lanickova, Lenka Kasikova, Jana Drozenova, David Cibula, Beatriz Álvarez-Abril, Elena García-Martínez, Radek Spisek & Lorenzo Galluzzi. (2022) Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer 8:5, pages 426-444.
Crossref
Nicole E. James, Morgan Woodman & Jennifer R. Ribeiro. (2022) Prognostic immunologic signatures in epithelial ovarian cancer. Oncogene 41:10, pages 1389-1396.
Crossref
Rami Vanguri, Jamal Benhamida, Jonathan H. Young, Yanyun Li, Oliver Zivanovic, Dennis Chi, Alexandra Snyder, Travis J. Hollmann & Katherine L. Mager. (2022) Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer. Gynecologic Oncology Reports 39, pages 100926.
Crossref
Hagma H. Workel, Nienke van Rooij, Annechien Plat, Diana C.J. Spierings, Rudolf S. N. Fehrmann, Hans W. Nijman & Marco de Bruyn. (2020) Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer. International Journal of Molecular Sciences 21:11, pages 3770.
Crossref